Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Heart failure after myocardial infarction: incidence and predictors

D. Jenča, V. Melenovský, J. Stehlik, V. Staněk, J. Kettner, J. Kautzner, V. Adámková, P. Wohlfahrt

. 2021 ; 8 (1) : 222-237. [pub] 20201214

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21026112

AIMS: The aim of the present paper was to provide an up-to-date view on epidemiology and risk factors of heart failure (HF) development after myocardial infarction. METHODS AND RESULTS: Based on literature review, several clinical risk factors and biochemical, genetic, and imaging biomarkers were identified to predict the risk of HF development after myocardial infarction. CONCLUSIONS: Heart failure is still a frequent complication of myocardial infarction. Timely identification of subjects at risk for HF development using a multimodality approach, and early initiation of guideline-directed HF therapy in these patients, can decrease the HF burden.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026112
003      
CZ-PrNML
005      
20211026133211.0
007      
ta
008      
211013s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ehf2.13144 $2 doi
035    __
$a (PubMed)33319509
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Jenča, Dominik $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Third Faculty of Medicine, Charles University, Prague, Czech Republic
245    10
$a Heart failure after myocardial infarction: incidence and predictors / $c D. Jenča, V. Melenovský, J. Stehlik, V. Staněk, J. Kettner, J. Kautzner, V. Adámková, P. Wohlfahrt
520    9_
$a AIMS: The aim of the present paper was to provide an up-to-date view on epidemiology and risk factors of heart failure (HF) development after myocardial infarction. METHODS AND RESULTS: Based on literature review, several clinical risk factors and biochemical, genetic, and imaging biomarkers were identified to predict the risk of HF development after myocardial infarction. CONCLUSIONS: Heart failure is still a frequent complication of myocardial infarction. Timely identification of subjects at risk for HF development using a multimodality approach, and early initiation of guideline-directed HF therapy in these patients, can decrease the HF burden.
650    _2
$a biologické markery $7 D015415
650    12
$a srdeční selhání $x epidemiologie $x etiologie $7 D006333
650    _2
$a lidé $7 D006801
650    _2
$a incidence $7 D015994
650    12
$a infarkt myokardu $x komplikace $x diagnóza $x epidemiologie $7 D009203
650    _2
$a rizikové faktory $7 D012307
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Melenovský, Vojtěch $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Stehlik, Josef $u Division of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA
700    1_
$a Staněk, Vladimír $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Kettner, Jiří $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Kautzner, Josef $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Faculty of Medicine, Dentistry of the Palacký University, Olomouc, Czech Republic
700    1_
$a Adámková, Věra $u Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Wohlfahrt, Peter $u Third Faculty of Medicine, Charles University, Prague, Czech Republic $u Division of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA $u Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Centre for Cardiovascular Prevention, First Faculty of Medicine and Thomayer Hospital, Charles University, Videnska 800, Prague 4, 140 59, Czech Republic
773    0_
$w MED00197251 $t ESC heart failure $x 2055-5822 $g Roč. 8, č. 1 (2021), s. 222-237
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33319509 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133217 $b ABA008
999    __
$a ok $b bmc $g 1714968 $s 1146619
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 8 $c 1 $d 222-237 $e 20201214 $i 2055-5822 $m ESC heart failure $n ESC Heart Fail $x MED00197251
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Možnosti archivace